Intelligence Platform
Patents
Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9994547
Heteroarylamide inhibitors of TBK1
granted patentUS 9988397
ERK inhibitors
granted patentUS 9987284
Substituted benzooxadiazole DNA-PK inhibitors
granted patentUS 9981999
Neprilysin inhibitors
granted patentUS 9981961
Deoxycytidine kinase inhibitors
granted patentUS 9981944
GDF-8 inhibitors
granted patentUS 9980976
Use of REDD1 inhibitors to dissociate therapeutic and adverse atrophogenic effects of gluc
granted patentUS 9975878
Substituted triazine BMI-1 inhibitors
granted patentUS 9974796
Inhibitors of the plasmodial surface anion channel as antimalarials
granted patentUS 9962379
Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use
granted patentUS 9962377
Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
granted patentUS 9957329
Factor XII inhibitors for the treatment of neurological inflammatory disorders
granted patentUS 9957281
Benzodiazepine derivatives as RSV inhibitors
granted patentUS 9957259
Selective HDAC1 and HDAC2 inhibitors
granted patentUS 9956215
Methods of treating cancer with farnesyltransferase inhibitors
granted patentUS 9951078
Inhibitors of ERK and methods of use
granted patentUS 9951014
Mammalian and bacterial nitric oxide synthase inhibitors
granted patentUS 9949932
Formulation of syk inhibitors
granted patentUS 9944626
6-(5-hydroxy-1H-pyrazol-1-YL)nicotinamide inhibitors of PHD
granted patentUS 9937228
Treatment of myocardial infarction by inhibiting the action of mAKAPΞ²
granted patentUS 9937157
Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inh
granted patentUS 9937155
Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase in
granted patentUS 9931340
Pyridazinone compounds and their use as DAAO inhibitors
granted patentUS 9925188
DNA-PK inhibitors and uses thereof
granted